Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study.

Shinya FurukawaTeruki MiyakeHiroaki MiyaokaBunzo MatsuuraYoichi Hiasa

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

Luseogliflozin might be more effective for controlling plasma glucose in patients with type 2 diabetes who have a tendency to eat fast, but it might have less effect on those with other unhealthy eating habits.

Keyphrases

weight loss
physical activity
type diabetes
cardiovascular disease
glycemic control
metabolic syndrome